Index Ventures News http://www.indexventures.com/ 2010-03-17T11:05:44Z Index Ventures info@indexventures.com Mike talks to the FT 2010-03-17T11:05:44Z 242 http://blogs.ft.com/techblog/http://blogs.ft.com/techblog/ Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease 2010-03-10T18:23:58Z 241 Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary EpisphereTM technology in the emerging field of epigenetics as... Dom Vidal - The Sunday Interview in The Telegraph 2010-02-25T15:40:07Z 240 Index Ventures' Dom Vidal tells The Sunday Telegraph's Andrew Cave why the future for growth investing is far from bleak. Click here to download the article in PDF format. Marten Mickos joins Index as European Entrepreneur-in-Residence 2010-01-28T11:20:04Z 238 Index Ventures, a leading venture capital firm today announced that Marten Mickos has joined the firm as a European Entrepreneur-in-Residence.  Mickos will focus on seeking out new investment opportunities within the European... Mimecast secures £13 million in Series B funding from leading investors 2010-01-25T15:03:10Z 237 Mimecast®, a holistic email management company offering SaaS-based email archiving, continuity, security and policy control, today announced that  it has received £13 million (USD $21 million) in Series B financing from... Boku raises $25 million in series C funding 2010-01-19T13:17:42Z 236 BOKU, Inc., a leader in mobile payments, announced today that it has raised $25 million in series C capital led by DAG Ventures, Inc. with continued participation from Benchmark Capital, Index Ventures and Khosla Ventures. This round of... Molecular Partners Secures CHF 46 million in Series B Financing 2009-12-15T12:10:59Z 235 Molecular Partners AG, a pioneer in the development of DARPins as next generation protein therapeutics, has announced the closing of its Series B equity investment round securing CHF 46 million (€ 30 million, $ 45 million).The round... PanGenetics announces acquisition by Abbott of PG110 anti-NGF antibody to treat chronic pain. 2009-11-12T13:14:16Z 234 PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott (NYSE: ABT) under which Abbott will acquire the global... Index and Accel Announce Exit of Playfish to Electronic Arts 2009-11-09T17:03:45Z 233 Index Ventures and Accel Partners, two leading global venture capital firms, today announce the sale of portfolio company Playfish Inc. to Electronic Arts (NASDAQ: ERTS).  Playfish was acquired for a consideration of up to $400... Electronic Arts Acquires Playfish 2009-11-09T15:23:28Z 232 Electronic Arts Inc. (NASDAQ: ERTS) today announced it has acquired PlayfishTM, a leading creator of social network games. The acquisition accelerates EA's position in social entertainment and strengthens its focus on the transition to...